|Bid||43.45 x 2200|
|Ask||43.75 x 2200|
|Day's range||42.22 - 43.83|
|52-week range||41.00 - 57.05|
|Beta (5Y monthly)||0.52|
|PE ratio (TTM)||26.56|
|Earnings date||28 Jul 2022|
|Forward dividend & yield||3.60 (7.95%)|
|Ex-dividend date||14 Jun 2022|
|1y target est||55.89|
The Food and Drug Administration (FDA) is trying to remove one of the biggest, most popular electronic cigarettes from the market, opening the way for its rival to become the unassailable leader in smoking alternatives. Although the regulatory agency delivered what appeared to be a death blow to Juul Labs by rejecting its marketing application for the Juul device and requiring it to take all its products off store shelves, Juul won a temporary reprieve from an appeals court, which stayed the order until it can decide on the merits of the case. Juul is partially owned by tobacco giant Altria (NYSE: MO), which acquired a 34% stake in the e-cig maker in 2018 for $12.8 billion.
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss Juul's request to block the FDA ban on it's e-cigarettes.
Food and Drug Administration ban on sale of company’s e-cigarette products leaves stock looking cheap